Calamos Advisors LLC Insulet Corp Transaction History

Calamos Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$127.77 - $221.42 $761,125 - $1.32 Million	5,957 New	5,957 $1.29 Million
Q1 2021 Apr 12, 2021	SELL	$235.95 - $293.05 $554,246 - $688,374	-2,349 Closed	0 $0
Q4 2020 Jan 27, 2021	SELL	$215.97 - $265.89 $382,266 - $470,625	-1,770 Reduced 42.97%	2,349 $600,000
Q3 2020 Oct 26, 2020	SELL	$192.55 - $236.59 $8,664 - $10,646	-45 Reduced 1.08%	4,119 $975,000
Q2 2020 Jul 27, 2020	SELL	$159.17 - $224.73 $196,574 - $277,541	-1,235 Reduced 22.87%	4,164 $809,000
Q1 2020 Apr 28, 2020	SELL	$130.01 - $216.44 $852,215 - $1.42 Million	-6,555 Reduced 54.84%	5,399 $894,000
Q4 2019 Jan 15, 2020	SELL	$144.81 - $186.0 $716,085 - $919,770	-4,945 Reduced 29.26%	11,954 $2.05 Million
Q3 2019 Oct 21, 2019	BUY	$117.35 - $167.95 $353,223 - $505,529	3,010 Added 21.67%	16,899 $2.79 Million
Q2 2019 Aug 07, 2019	BUY	$82.13 - $120.73 $1.14 Million - $1.68 Million	13,889 New	13,889 $1.66 Million

687

62.7M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $19.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Advisors LLC with notifications on news.